Dossier assessment
Vericiguat (cardiac failure) - Benefit assessment according to §35a Social Code Book V
Report documents
-
Extract of dossier assessment
Vericiguat (cardiac failure) - Benefit assessment according to §35a Social Code Book V
-
Dossier assessment
Vericiguat (cardiac failure) - Benefit assessment according to §35a Social Code Book V
Dossier assessment
Adults with symptomatic chronic heart failure with reduced ejection fraction who are stabilized after a recent decompensation event requiring intravenous therapy
- Age < 75 years: hint of a non-quantifiable added benefit.
- Age ≥ 75 years: added benefit not proven.
Additional information
Federal Joint Committee (G-BA)
2022-03-03 A G-BA decision was published.
Project details
- Project no.
- A21-120
- Commission
- Commission awarded on 15.09.2021 by the Federal Joint Committee (GBA).
- Report type
- Dossier assessment
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Heart and circulation
- Note
-
After completion of the assessment by IQWiG the Federal Joint Committee (GBA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the GBA website.